Works matching DE "THERAPEUTIC use of monoclonal antibodies"

Results: 5000

Dose finding in early-phase human immunodeficiency virus type 1 prevention monoclonal antibody clinical trials.

Published in:

Clinical Trials, 2025, v. 22, n. 4, p. 442, doi. 10.1177/17407745251347280

By:

Huang, Yunda;
Zhang, Bo;
Zhang, Lily;
Mayer, Bryan T;
Martin, Troy;
Hahn, William;
Hyrien, Ollivier;
Gelderblom, Huub C

Publication type:

Article

Calcitonin gene-related peptide monoclonal antibody treatment for new daily persistent headache.

Published in:

Journal of Headache & Pain, 2025, v. 26, n. 1, p. 1, doi. 10.1186/s10194-025-02111-2

By:

Cheema, Sanjay;
Rantell, Khadija Rerhou;
Pickering, Rachel;
Lagrata, Susie;
Kamourieh, Salwa;
Matharu, Manjit

Publication type:

Article

Population-Based Analysis of the Risk of Mycobacterial Infections Associated With Immune Checkpoint Inhibitors Open Access.

Published in:

Clinical Infectious Diseases, 2025, v. 81, n. 1, p. 176, doi. 10.1093/cid/ciae626

By:

Yan, Marie;
Hernandez, Alejandro;
Chan, Kelvin K;
Stanbrook, Matthew B;
Blanchette, Phillip S;
Johnston, James C;
Lee, Samantha M;
Macdonald, Liane;
Richard-Greenblatt, Melissa;
Marras, Theodore K;
Brode, Sarah K

Publication type:

Article

A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease.

Published in:

COPD: Journal of Chronic Obstructive Pulmonary Disease, 2017, v. 14, n. 5, p. 476, doi. 10.1080/15412555.2017.1335697

By:

Eich, Andreas;
Urban, Veronika;
Jutel, Marek;
Vlcek, Jiri;
Shim, Jae Jeong;
Trofimov, Vasiliy I.;
Liam, Chong-Kin;
Kuo, Ping-Hung;
Hou, Yanyan;
Xiao, Jun;
Branigan, Patrick;
O'Brien, Christopher D.

Publication type:

Article

Effective treatments for respiratory syncytial virus infection in children remain elusive but prevention tools are now available.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 5, p. 177, doi. 10.1007/s40267-025-01157-1

By:

Shirley, Matt

Publication type:

Article

Manage chronic hand eczema with conventional treatments, but emerging therapies show promise.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 4, p. 146, doi. 10.1007/s40267-025-01155-3

By:

Zhuang-Yan, Amy

Publication type:

Article

Regulatory and clinical aspects in biosimilar medicines: comparability, extrapolation, interchangeability, and safety: Biosimilar medicines: evaluating comparability, extrapolation, interchangeability, and safety: M. C. Raposo et al.

Published in:

Drugs & Therapy Perspectives, 2025, v. 41, n. 3, p. 111, doi. 10.1007/s40267-025-01145-5

By:

Raposo, Miguel C.;
Feiteira, Cláudia;
Ribeiro, Maria H. L.

Publication type:

Article

Correction: Rozanolixizumab in generalized myasthenia gravis: a profile of its use.

Published in:

2024

By:

Hoy, Sheridan M.

Publication type:

Correction Notice

Mirikizumab in moderately to severely active ulcerative colitis: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 11, p. 433, doi. 10.1007/s40267-024-01114-4

By:

Fung, Simon;
Blair, Hannah A.

Publication type:

Article

Lecanemab in Alzheimer's disease: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 10, p. 393, doi. 10.1007/s40267-024-01108-2

By:

Blair, Hannah A.

Publication type:

Article

Adis summary of research: Omalizumab in severe asthma: effect on oral corticosteroid exposure and remodelling. A randomized open-label parallel study.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 8, p. 291, doi. 10.1007/s40267-024-01083-8

By:

Syed, Yahiya Y.

Publication type:

Article

Rozanolixizumab in generalized myasthenia gravis: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 6, p. 203, doi. 10.1007/s40267-024-01077-6

By:

Hoy, Sheridan M.

Publication type:

Article

Aim to alleviate alopecia areata with newly available agents.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 5, p. 181, doi. 10.1007/s40267-024-01069-6

By:

Fenton, Caroline;
Kang, Connie

Publication type:

Article

Mirvetuximab soravtansine in folate receptor alpha-positive, platinum-resistant ovarian cancers: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2024, v. 40, n. 2, p. 53, doi. 10.1007/s40267-024-01050-3

By:

Fung, Simon;
Syed, Yahiya Y.

Publication type:

Article

Correction to: Tezepelumab in severe asthma: a profile of its use.

Published in:

2024

By:

Syed, Yahiya Y.

Publication type:

Correction Notice

Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 413, doi. 10.1007/s40267-023-01039-4

By:

Shirley, Matt

Publication type:

Article

The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 432, doi. 10.1007/s40267-023-01038-5

By:

Munzone, Elisabetta;
Fabi, Alessandra;
Buono, Giuseppe;
Caputo, Roberta;
Montagna, Emilia;
Negri, Mara;
Nuzzo, Francesco;
Palazzo, Antonella;
Paris, Ida;
Conti, Luca;
Baggi, Anna;
Franzini, Jean Marie;
De Laurentiis, Michelino

Publication type:

Article

Spesolimab in generalised pustular psoriasis flares: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 404, doi. 10.1007/s40267-023-01034-9

By:

Nie, Tina

Publication type:

Article

Tezepelumab in severe asthma: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 12, p. 393, doi. 10.1007/s40267-023-01033-w

By:

Syed, Yahiya Y.

Publication type:

Article

Ublituximab in relapsing forms of multiple sclerosis: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 11, p. 365, doi. 10.1007/s40267-023-01030-z

By:

Blair, Hannah A.

Publication type:

Article

Consider new therapies for the treatment and prevention of Clostridioides difficile infection.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 7, p. 237, doi. 10.1007/s40267-023-01006-z

By:

Fenton, Caroline;
Kang, Connie

Publication type:

Article

Calcitonin gene-related peptide-targeted therapies are effective options for the prevention and treatment of migraine.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 6, p. 195, doi. 10.1007/s40267-023-00995-1

By:

Nie, Tina

Publication type:

Article

Nivolumab/relatlimab in advanced melanoma: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2023, v. 39, n. 3, p. 89, doi. 10.1007/s40267-023-00980-8

By:

Lee, Arnold

Publication type:

Article

Aducanumab: a review of the first approved amyloid-targeting antibody for Alzheimer's disease.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 10, p. 443, doi. 10.1007/s40267-022-00944-4

By:

Grover, Shubhima;
Jain, Seema

Publication type:

Article

Tisotumab vedotin-tftv in previously treated recurrent or metastatic cervical cancer: a profile of its use in the USA.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 9, p. 382, doi. 10.1007/s40267-022-00939-1

By:

Kim, Esther S.;
Al-Salama, Zaina T.

Publication type:

Article

Anifrolumab in systemic lupus erythematosus: a profile of its use.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 7, p. 293, doi. 10.1007/s40267-022-00925-7

By:

Lamb, Yvette N.

Publication type:

Article

Loncastuximab tesirine in relapsed or refractory diffuse large B-cell lymphoma: a profile of its use in the USA.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 6, p. 261, doi. 10.1007/s40267-022-00922-w

By:

Markham, Anthony;
Al-Salama, Zaina T.

Publication type:

Article

Targeted therapy for metastatic colorectal cancer: what do we currently have in clinical practice?

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 5, p. 222, doi. 10.1007/s40267-022-00915-9

By:

Morgado, Sandra;
Silva, Mafalda;
Fonseca, Olímpia;
Roque, Fátima;
Morgado, Manuel

Publication type:

Article

Emerging small molecule antivirals may fit neatly into COVID-19 treatment.

Published in:

Drugs & Therapy Perspectives, 2022, v. 38, n. 3, p. 112, doi. 10.1007/s40267-022-00897-8

By:

Fenton, Caroline;
Keam, Susan J.

Publication type:

Article

Effectiveness of Combined I-chTNT and Radiofrequency Ablation Therapy in Treating Advanced Hepatocellular Carcinoma.

Published in:

Cell Biochemistry & Biophysics, 2015, v. 71, n. 2, p. 777, doi. 10.1007/s12013-014-0262-4

By:

Tu, Jianfei;
Ji, Jiansong;
Wu, Fazong;
Wang, Yonghui;
Zhang, Dengke;
Zhao, Zhongwei;
Ying, Xihui

Publication type:

Article

Expression of Sclerostin scFv and the Effect of Sclerostin scFv on Healing of Osteoporotic Femur Fracture in Rats.

Published in:

Cell Biochemistry & Biophysics, 2014, v. 69, n. 2, p. 229, doi. 10.1007/s12013-013-9787-1

By:

Yao, Qi;
Ni, Jie;
Hou, Yu;
Ding, Lixiang;
Zhang, Licheng;
Jiang, Hua

Publication type:

Article

The Effect of c-fos on Acute Myocardial Infarction and the Significance of Metoprolol Intervention in a Rat Model.

Published in:

Cell Biochemistry & Biophysics, 2013, v. 65, n. 2, p. 249, doi. 10.1007/s12013-012-9428-0

By:

Zhang, Song;
Zhang, Meiqi;
Goldstein, Steven;
Li, Yigang;
Ge, Junbo;
He, Ben;
Ruiz, George

Publication type:

Article

A case study of a patient with platelet transfusion refractoriness (PTR) combined with human leucocyte antigen (HLA) antibody positivity during hepatic arterial infusion chemotherapy in conjunction with the 'atezolizumab plus bevacizumab' regimen.

Published in:

Nursing in Critical Care, 2025, v. 30, n. 2, p. 1, doi. 10.1111/nicc.13118

By:

Xie, Yawen;
Huang, Yanxia;
Liu, Shuyue

Publication type:

Article

Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.

Published in:

Cardiovascular Drugs & Therapy, 2016, v. 30, n. 3, p. 297, doi. 10.1007/s10557-016-6655-4

By:

Cho, Leslie;
Rocco, Michael;
Colquhoun, David;
Sullivan, David;
Rosenson, Robert;
Dent, Ricardo;
Xue, Allen;
Scott, Rob;
Wasserman, Scott;
Stroes, Erik

Publication type:

Article

Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice.

Published in:

Molecular Medicine, 2016, v. 22, p. 12, doi. 10.2119/molmed.2015.00176

By:

Schaper, Fleur;
van Timmeren, Mirjan M.;
Petersen, Arjen;
Horst, Gerda;
Bijl, Marc;
Limburg, Pieter C.;
Westra, Johanna;
Heeringa, Peter

Publication type:

Article

A Superagonistic Monoclonal Antibody for CD28 Ameliorates Crescentic Glomerulonephritis in Wistar-Kyoto Rats.

Published in:

Molecular Medicine, 2011, v. 17, n. 7/8, p. 686, doi. 10.2119/molmed.2010.00229

By:

Takabatake, Yoshitsugu;
Li, Xiao-Kang;
Mizui, Masayuki;
Miyasato, Kenro;
Matsui, Isao;
Kawada, Noritaka;
Imai, Enyu;
Hünig, Thomas;
Takahara, Shiro;
Wada, Takashi;
Furuichi57,8, Kengo;
Rakugi, Hiromi;
Isaka, Yoshitaka

Publication type:

Article

A proof-of-concept study on CGRP plasma levels of migraineurs during a 6-month treatment with ERENUMAB.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s10194-020-01193-4

By:

Tringali, Giuseppe;
Vollono, Catello;
Calabresi, Paolo;
Navarra, Pierluigi

Publication type:

Article

Improvements in pain, medication use and quality of life in onabotulinumtoxinA-resistant chronic migraine patients following erenumab treatment – real world outcomes.

Published in:

Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-020-01214-2

By:

Talbot, J.;
Stuckey, R.;
Crawford, L.;
Weatherby, S.;
Mullin, S.

Publication type:

Article

Treatment benefit among migraine patients taking fremanezumab: results from a post hoc responder analysis of two placebo-controlled trials.

Published in:

Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-020-01212-4

By:

Silberstein, Stephen D.;
Cohen, Joshua M.;
Yang, Ronghua;
Gandhi, Sanjay K.;
Du, Evelyn;
Jann, Adelene E.;
Marmura, Michael J.

Publication type:

Article

Association between response to triptans and response to erenumab: real-life data.

Published in:

Journal of Headache & Pain, 2021, v. 22, n. 1, p. 1, doi. 10.1186/s10194-020-01213-3

By:

Frattale, Ilaria;
Caponnetto, Valeria;
Casalena, Alfonsina;
Assetta, Maurizio;
Maddestra, Maurizio;
Marzoli, Fabio;
Affaitati, Giannapia;
Giamberardino, Maria Adele;
Viola, Stefano;
Gabriele, Amleto;
Pistoia, Francesca;
Cerone, Davide;
Marini, Carmine;
Sacco, Simona;
Ornello, Raffaele

Publication type:

Article

Eptinezumab for the prevention of chronic migraine: efficacy and safety through 24 weeks of treatment in the phase 3 PROMISE-2 (Prevention of migraine via intravenous ALD403 safety and efficacy–2) study.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s10194-020-01186-3

By:

Silberstein, Stephen;
Diamond, Merle;
Hindiyeh, Nada A.;
Biondi, David M.;
Cady, Roger;
Hirman, Joe;
Allan, Brent;
Pederson, Susan;
Schaeffler, Barbara;
Smith, Jeff

Publication type:

Article

Impact of galcanezumab on total pain burden: findings from phase 3 randomized, double-blind, placebo-controlled studies in patients with episodic or chronic migraine (EVOLVE-1, EVOLVE-2, and REGAIN trials).

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01190-7

By:

Ailani, Jessica;
Andrews, J. Scott;
Rettiganti, Mallikarjuna;
Nicholson, Robert A.

Publication type:

Article

The impact of fremanezumab on medication overuse in patients with chronic migraine: subgroup analysis of the HALO CM study.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s10194-020-01173-8

By:

Silberstein, Stephen D.;
Cohen, Joshua M.;
Seminerio, Michael J.;
Yang, Ronghua;
Ashina, Sait;
Katsarava, Zaza

Publication type:

Article

Improvements across a range of patient-reported domains with fremanezumab treatment: results from a patient survey study.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s10194-020-01177-4

By:

Buse, Dawn C.;
Gandhi, Sanjay K.;
Cohen, Joshua M.;
Ramirez-Campos, Verena;
Cloud, Blaine;
Yang, Ronghua;
Cowan, Robert P.

Publication type:

Article

Conversion from chronic to episodic migraine in patients treated with erenumab: real-life data from an Italian region.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. N.PAG, doi. 10.1186/s10194-020-01171-w

By:

Ornello, Raffaele;
Casalena, Alfonsina;
Frattale, Ilaria;
Caponnetto, Valeria;
Gabriele, Amleto;
Affaitati, Giannapia;
Giamberardino, Maria Adele;
Assetta, Maurizio;
Maddestra, Maurizio;
Marzoli, Fabio;
Viola, Stefano;
Cerone, Davide;
Marini, Carmine;
Pistoia, Francesca;
Sacco, Simona

Publication type:

Article

Efficacy and safety of erenumab in women with a history of menstrual migraine.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01167-6

By:

Pavlovic, Jelena M.;
Paemeleire, Koen;
Göbel, Hartmut;
Bonner, Jo;
Rapoport, Alan;
Kagan, Risa;
Zhang, Feng;
Picard, Hernan;
Mikol, Daniel D.

Publication type:

Article

Erenumab in highly therapy-refractory migraine patients: First German real-world evidence.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01151-0

By:

Scheffler, Armin;
Messel, Olga;
Wurthmann, Sebastian;
Nsaka, Michael;
Kleinschnitz, Christoph;
Glas, Martin;
Naegel, Steffen;
Holle, Dagny

Publication type:

Article

A prospective real-world analysis of erenumab in refractory chronic migraine.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01127-0

By:

Lambru, Giorgio;
Hill, Bethany;
Murphy, Madeleine;
Tylova, Ivona;
Andreou, Anna P.

Publication type:

Article

13th European Headache Federation Congress 2019: Meeting Abstracts - part 2: Athens, Greece. May 30–June 12,2019.

Published in:: 2020
Publication type:: Abstract

Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy.

Published in:

Journal of Headache & Pain, 2020, v. 21, n. 1, p. 1, doi. 10.1186/s10194-020-01102-9

By:

Ornello, Raffaele;
Casalena, Alfonsina;
Frattale, Ilaria;
Gabriele, Amleto;
Affaitati, Giannapia;
Giamberardino, Maria Adele;
Assetta, Maurizio;
Maddestra, Maurizio;
Marzoli, Fabio;
Viola, Stefano;
Cerone, Davide;
Marini, Carmine;
Pistoia, Francesca;
Sacco, Simona

Publication type:

Article